Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board

Bedfont, who has specialized in the design and manufacture of breath analysis medical devices for over 40 years, announces today that Dr Jafar Jafari will be the first appointment to its Gastrolyzer Medical Advisory Board.

Head of Upper GI Physiology at the Guy’s and St Thomas’ Foundation Trust Hospitals, Dr Jafari has an MD in Medicine, a PhD in Neurogastroenterology, and has been involved in over 100 research publications regarding gastroenterology.  Notably, one of Dr Jafari’s main areas of interest is Hydrogen and C13 GI breath testing.

The Gastrolyzer range works by measuring exhaled levels of hydrogen and methane that are produced when the gut breaks down food; interpreting these gas levels can help to determine gastrointestinal disorders such as lactose intolerance, IBS (Irritable Bowel Syndrome) and more.

We are privileged to welcome Dr Jafari into our Bedfont Family and onto our Gastrolyzer Medical Advisory Board. We are very fortunate to be able to call upon his extensive knowledge and expertise in the gastrointestinal field.”

Jason Smith, Managing Director

The Gastrolyzer range provides an instant, non-invasive and easy-to-use method for healthcare professionals and patients to use when investigating gut function. I am privileged to have been given this opportunity to contribute to Bedfont’s GI breath testing campaign.”

Dr Jafar Jafari

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bedfont® Scientific Ltd. (2019, June 19). Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/news/20190118/Bedfont-appoints-Dr-Jafar-Jafari-as-first-member-of-the-Gastrolyzer-Medical-Advisory-Board.aspx.

  • MLA

    Bedfont® Scientific Ltd. "Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board". News-Medical. 21 December 2024. <https://www.news-medical.net/news/20190118/Bedfont-appoints-Dr-Jafar-Jafari-as-first-member-of-the-Gastrolyzer-Medical-Advisory-Board.aspx>.

  • Chicago

    Bedfont® Scientific Ltd. "Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board". News-Medical. https://www.news-medical.net/news/20190118/Bedfont-appoints-Dr-Jafar-Jafari-as-first-member-of-the-Gastrolyzer-Medical-Advisory-Board.aspx. (accessed December 21, 2024).

  • Harvard

    Bedfont® Scientific Ltd. 2019. Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board. News-Medical, viewed 21 December 2024, https://www.news-medical.net/news/20190118/Bedfont-appoints-Dr-Jafar-Jafari-as-first-member-of-the-Gastrolyzer-Medical-Advisory-Board.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Empowering Asthma Care: Bedfont® Scientific Limited Provides Vital Support for FeNO Testing in Response to Updated NICE Asthma Guidelines